What is the share price of Lincoln Parenteral Ltd. (Amalgamated)?

Company share prices are keep on changing according to the market conditions. The current trading price of Lincoln Parenteral Ltd. (Amalgamated) on 01-Jan-1970 05:30:00 at 05:30 is .

What is the P/E ratio of Lincoln Parenteral . (Amalgamated)?

The latest standalone P/E ratio of Lincoln Parenteral . (Amalgamated) as of 01-Jan-1970 is 0.00.

What is the P/B ratio of Lincoln Parenteral Ltd. (Amalgamated)?

The latest standalone P/B ratio of Lincoln Parenteral Ltd. (Amalgamated) as of 01-Jan-1970 is 0.00.

What is the 52-week high and low of Lincoln Parenteral Ltd. (Amalgamated)?

The 52-week high of Lincoln Parenteral Ltd. (Amalgamated) is Rs. and the 52-week low is Rs. .

Lincoln Parenteral Ltd. (Amalgamated) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: Lincoln Parenteral Ltd. (Amalgamated)
Brand: Lincoln Parenteral . (Amalgamated)

Lincoln Parenteral Ltd. (Amalgamated)

Key Metrics

Valuation Multiples

Market Cap

₹0 Cr.

Current Price

₹0

52-Week Low / High

₹0 / 0

TTM EPS

₹0

TTM Sales

₹44.6 Cr.

Book Value per Share

P/E Ratio

0.00

Industry PE

Price to Book (P/B)

0.00

Price to Sales (P/S)

0.00

EV/EBITDA

0.00

Dividend Yield

0.00%

Profitability Efficiency

Return on Equity (ROE)

7.03%

Return on Capital Employed (ROCE)

14.59%

Return on Assets (ROA)

3.29%

Operating Profit Margin

12.7%

Net Profit Margin

4.13%

Gross Profit Margin

10.2%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Improving versus 3-year growth rate

0.65%

Operating Profit Growth (1 Year)

Slowing versus 3-year growth rate

-6.11%

Net Profit Growth (1 Year)

Improving versus 3-year growth rate

-3.66%

Asset Quality

Promoter Holding

98.58%

Pledged shares (%) of Promoter's holding (%)

0.00%

Reserves

₹17 Cr.

Equity

₹0 Cr.

Face Value

₹10

All Time Low / High

- / -

Lincoln Parenteral . (Amalgamated) stock performance

Key Ratios

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	TTM
ROCE % ⓘ	-0.4%	1.8%	2.6%	5.6%	16.8%	7.6%	13.4%	21%	17.6%	14.6%	-
Value Creation Index ⓘ	-1.0	-0.9	-0.8	-0.6	0.2	-0.5	0.0	0.5	0.3	0.0	-
Growth Parameters ⓘ
Sales ⓘ	8	7.9	27.5	67.1	110	62.2	70.8	50.9	44.4	44.6	45
Sales YoY Gr.	-	-1%	247.6%	144.2%	64%	-43.5%	13.8%	-28.1%	-12.8%	0.7%	-
Adj EPS ⓘ	0.2	-0.8	-1.2	0.5	2.1	1.7	1.9	2	1.9	1.8	0
YoY Gr.	-	-472.7%	NA	NA	355.6%	-16.6%	8.8%	9.1%	-6.4%	-3.7%	-
BVPS (₹) ⓘ	11.3	11	9.8	9.9	12	13.7	21.4	23.4	25.3	27.1	0
Adj Net Profit ⓘ	0.2	-0.8	-1.2	0.5	2.1	1.7	1.9	2	1.9	1.8	0
Cash Flow from Ops. ⓘ	0.6	-7.7	-3.1	15.4	-0.2	0.9	5.3	4.9	2.4	-2	-
Debt/CF from Ops. ⓘ	27.5	-4.3	-13.1	2.1	-183.4	45.3	1	0	0.2	0	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	21.1%	-16.5%	-14.2%	0.7%
Adj EPS ⓘ	26.5%	-2.2%	-0.5%	-3.7%
BVPSⓘ	10.2%	17.8%	8.2%	7.2%
Share Price	-	-	-	-

Key Financial Parameters ⓘ

	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	TTM
Return on Equity % ⓘ	2	-7.3	-11.9	4.6	18.8	13.3	10.6	9.1	7.8	7	0
Op. Profit Mgn % ⓘ	2.7	-5.3	5	4.3	7.3	6.7	8.9	13.2	13.7	12.7	NAN
Net Profit Mgn % ⓘ	2.8	-10.4	-4.5	0.7	1.9	2.8	2.6	4	4.3	4.1	0
Debt to Equity ⓘ	1.5	3	4.2	3.2	3.4	3	0.3	0	0	0	-
Working Cap Days ⓘ	534	778	388	218	120	179	179	243	274	265	0
Cash Conv. Cycle ⓘ	10	-2	-3	13	12	35	57	68	67	65	0

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21
Sales	7.98	7.90	27.46	67.05	109.95	62.18	70.78	50.87	44.35	44.64
Operating Expenses ⓘ +	8.09	8.32	26.09	64.55	101.94	58.05	64.47	44.16	38.30	38.96
Manufacturing Costs	0.10	0.70	1.86	9.41	13.22	14.61	19.89	22.90	24.32	21.30
Material Costs	6.45	4.58	20.30	52.10	86.05	40.38	39.36	17.26	8.92	12.66
Employee Cost	0.84	1.65	2.76	2.02	2.10	2.54	3.64	3.33	3.75	4.21
Other Costs ⓘ	0.71	1.39	1.17	1.02	0.57	0.53	1.58	0.66	1.30	0.78
Operating Profit ⓘ	-0.11	-0.42	1.38	2.50	8.01	4.13	6.30	6.71	6.06	5.69
Operating Profit Margin (%)	-1.4%	-5.3%	5.0%	3.7%	7.3%	6.6%	8.9%	13.2%	13.7%	12.7%
Other Income ⓘ +	0.08	1.64	1.07	1.72	1.60	1.59	0.81	0.30	0.13	0.06
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Interest ⓘ	0.03	0.68	1.67	2.03	4.95	1.58	2.26	1.32	1.20	1.19
Depreciation ⓘ	0.05	0.57	1.25	1.64	1.65	1.66	1.71	1.76	1.86	1.89
Profit Before Tax ⓘ	-0.11	-0.03	-0.47	0.55	3.01	2.48	3.14	3.93	3.13	2.66
Tax ⓘ	-0.13	0.31	0.77	0.39	0.95	0.78	1.22	1.90	1.22	0.81
Profit After Tax	0.02	-0.34	-1.24	0.17	2.05	1.71	1.91	2.03	1.91	1.84
PAT Margin (%)	0.3%	-4.3%	-4.5%	0.3%	1.9%	2.8%	2.7%	4.0%	4.3%	4.1%
Adjusted EPS (₹)	0.0	-0.3	-1.2	0.2	2.1	1.7	1.9	2.0	1.9	1.8
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Valuation of Lincoln Parenteral - Standalone

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21
Equity and Liabilities
Shareholders Fund +	11.32	10.99	9.75	9.92	11.97	13.68	21.40	23.42	25.31	27.12
Share Capital ⓘ	10	10	10	10	10	10	10	10	10	10
Reserves ⓘ	1.32	0.99	-0.25	-0.08	1.97	3.68	11.40	13.42	15.31	17.12
Debt +	17.40	32.79	40.66	32.07	40.75	40.30	0.79	0	0.33	0
Long Term Debt	17.40	32.79	40.21	29.04	38.19	39.25	0.79	0	0.33	0
Short Term Debt	0	0	0.45	3.02	2.56	1.05	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	0.05	3.74	17.46	31.90	6.33	7.49	7.93	6.59	8.45	6.20
Others Liabilities ⓘ	1.29	3.66	1.74	2.44	3.51	3.27	35.09	24.47	26.70	18.07
Total Liabilities ⓘ	30.07	51.18	69.61	76.32	62.56	64.74	65.22	54.48	60.79	51.40
Fixed Assets
Net Fixed Assets ⓘ +	0.68	27.36	28.56	27.52	26.08	25.41	24.40	23.23	22.47	20.74
Gross Block	1.46	28.72	31.16	31.76	31.86	32.85	27.78	28.37	29.46	29.62
Accumulated Depreciation	0.79	1.36	2.60	4.24	5.77	7.44	3.38	5.14	6.99	8.89
CWIP ⓘ	11.51	0	0	0	0	0	0	0.15	0	0.34
Investments ⓘ	0.41	0.40	0.40	0	0	0	0	0	0	0
Inventories	0.02	1.81	3	2.53	2.81	5.43	8.96	6.75	9.53	6.35
Trade Receivables	0.23	1.65	15.41	35.93	7.10	11.69	12.51	7.43	8.80	7.86
Cash Equivalents	4.92	0.50	2.92	5.20	7.25	6.20	4.11	0.02	2.91	0.90
Others Assets ⓘ	12.29	19.46	19.32	5.14	19.31	16	15.22	16.89	17.07	15.20
Total Assets ⓘ	30.07	51.18	69.61	76.32	62.56	64.74	65.22	54.48	60.79	51.40

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21
Cash Flow From Operating Activity ⓘ +	0.63	-7.68	-3.09	15.37	-0.22	0.89	5.32	4.88	2.36	-1.98
PBT ⓘ	-0.11	-0.03	-0.47	0.55	3.01	2.48	3.14	3.93	3.13	2.66
Adjustment ⓘ	0.35	0.55	2.60	3.15	5.49	2.16	3.66	2.78	3.06	3.08
Changes in Working Capital ⓘ	0.39	-8.2	-5.23	11.68	-8.36	-2.92	-0.92	-0.99	-3.05	-6.75
Tax Paid ⓘ	0	0	0	0	-0.37	-0.84	-0.56	-0.85	-0.78	-0.97
Cash Flow From Investing Activity ⓘ +	-10	-15.04	-2.17	-2.51	-1.87	1.05	1.85	1.01	0.12	0.48
Capex	-10.05	-15.74	-2.45	-0.21	-0.21	-0.99	-0.65	-0.76	-1.02	-0.47
Net Investments	0	0	-0.02	-2.30	-1.73	0.96	2.01	4.10	0	0
Others ⓘ	0.04	0.70	0.29	-0	0.07	1.08	0.49	-2.33	1.14	0.95
Cash Flow From Financing Activity ⓘ +	13.72	18.03	5.78	-12.88	1.99	-2.03	-7.25	-5.88	0.35	-0.45
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0	0	0	0	7.41	1.06	-5.28	-5.29	0.38	-0.38
Interest Paid ⓘ	-0.02	-0.67	-1.64	-1.72	-4.95	-1.58	-1.04	-0.59	-0.03	-0.07
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Others ⓘ	13.74	18.70	7.42	-11.16	-0.46	-1.52	-0.92	0	-0	0
Net Cash Flow ⓘ	4.35	-4.68	0.51	-0.02	-0.10	-0.09	-0.07	0	2.83	-1.94

Financial Ratio

PARTICULARS	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21
Ratios
ROE (%)	0.22	-3.02	-11.92	1.71	18.76	13.31	10.9	9.07	7.85	7.03
ROCE (%)	-0.37	1.79	2.55	5.59	16.82	7.61	13.39	20.95	17.64	14.59
Asset Turnover Ratio	0.36	0.2	0.47	0.93	1.59	1	1.1	0.85	0.77	0.8
PAT to CFO Conversion(x)	31.5	N/A	N/A	90.41	-0.11	0.52	2.79	2.4	1.24	-1.08
Working Capital Days
Receivable Days	18.50	41.10	109.20	137.60	71.10	54	62	71.60	66.80	68.20
Inventory Days	3.70	40.20	30.80	14.80	8.80	23.70	36.90	56.40	67	64.90
Payable Days	14.40	151.40	190.60	172.90	81.10	62.40	71.50	153.50	307.50	211.10

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Lincoln Parenteral Ltd. (Amalgamated) FAQs

The current trading price of Lincoln Parenteral on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Lincoln Parenteral stood at ₹0.00 Cr

The latest P/E ratio of Lincoln Parenteral as of 31-Dec-1969 is 0.00.

The latest P/B ratio of Lincoln Parenteral as of 31-Dec-1969 is 0.00.

The 52-week high of Lincoln Parenteral is ₹0.00 and the 52-week low is ₹0.00.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Lincoln Parenteral is ₹44.64 ( Cr.) .

Data is not available for this company.

No data found

About Lincoln Parenteral Ltd. (Amalgamated)

No data to display

Lincoln Parenteral Ltd. (Amalgamated)

Lincoln Parenteral Ltd. (Amalgamated)

Lincoln Parenteral . (Amalgamated) stock performance

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Lincoln Parenteral - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Lincoln Parenteral Ltd. (Amalgamated) FAQs

About Lincoln Parenteral Ltd. (Amalgamated)

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Lincoln Parenteral Ltd. (Amalgamated)

Lincoln Parenteral Ltd. (Amalgamated)

Lincoln Parenteral . (Amalgamated) stock performance

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Lincoln Parenteral - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Lincoln Parenteral Ltd. (Amalgamated) FAQs

What is the share price of Lincoln Parenteral?

What is the market cap of Lincoln Parenteral?

What is the P/E ratio of Lincoln Parenteral?

What is the P/B ratio of Lincoln Parenteral?

What is the 52-week high and low of Lincoln Parenteral?

What is the TTM revenue of Lincoln Parenteral?

Is a good quality company?

Is undervalued or overvalued?

Is a good buy now?

About Lincoln Parenteral Ltd. (Amalgamated)

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.